An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease
Clinical trial NCT00745615 · TERMINATED
Trial details
- NCT number
- NCT00745615
- Sponsor
- Teva Pharmaceutical Industries, Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-07
- Primary completion
- 2017-07-23
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.